Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BAY-6035 is an inhibitor of SET and MYND domain-containing protein 3 (SMYD3). BAY-6035 has more than 100-fold selectivity over other histone methyltransferases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 30.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 263.00 | |
50 mg | In stock | $ 428.00 | |
100 mg | In stock | $ 639.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | BAY-6035 is an inhibitor of SET and MYND domain-containing protein 3 (SMYD3). BAY-6035 has more than 100-fold selectivity over other histone methyltransferases. |
Targets&IC50 | SMYD3:88 nM (IC50) |
In vitro | BAY-6035 inhibits methylation of MEKK2 peptide in a cell-free assay and in cells with IC50s of 88 and 70 nM, respectively[1]. |
Molecular Weight | 396.48 |
Formula | C22H28N4O3 |
CAS No. | 2247890-13-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (239.61 mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BAY-6035 2247890-13-5 Chromatin/Epigenetic MAPK Histone Methyltransferase MEK BAY6035 inhibit MEKK2 BAY 6035 Inhibitor SMYD3 methylation inhibitor